TLP-H, EGCG, and Chlorogenic acid can also significantly alleviate intestinal dysbiosis and liver inflammation by inhibiting the activation of the TLR4/MyD88/NF-κB signaling pathway, thereby alleviating liver injury [139,140,142]. The gene discussed is NFKB1; the disease is inflammation.